RT @DrKanikaMonga: What contributes to serious infections in RA? Higher inflammation and GC use, not bDMARD or tofacitinib use increased in…
Tweet Content
What contributes to serious infections in RA? Higher inflammation and GC use, not bDMARD or tofacitinib use increased infectious risk
Bella Mehta et al. RMD Open 2019
#ACR19 @RheumNow
Show on Archive Page
On
Display in Search Results
On